The Korea Herald

Articles by Lim Jeong-yeo

LATEST NEWS

March 1, 2021 Industry

[Herald Interview] Carbon-neutral Philips sets higher goals for 2025

For anyone who has tried, it is evident that reducing one’s carbon footprint requires an extraordinary attention to the waste produced, coupled with a conscious effort to cut down on convenient habit...

GC WellBeing to repurpose liver drug as COVID-19 treatment

GC WellBeing will conduct a phase 2 clinical trial of its liver drug Laennec, to repurpose it as a COVID-19 treatment, the Ministry of Food and Drug Safety said Friday. This puts the total count of ...

February 26, 2021
Industry
Pfizer vaccine approval in Korea imminent, FDA allows more flexible storage

South Korea on Friday paved the way to approving Pfizer’s mRNA vaccine for COVID-19 as another group of pharmaceutical experts positively opined on the vaccine’s efficacy and safety. On the same day...

February 26, 2021
Industry
EMA starts rolling review of Celltrion’s COVID-19 treatment

European Medicines Agency said Wednesday, local time, that it has started a “rolling review” of data on South Korean company Celltrion’s monoclonal antibody regdanvimab. Regdanvimab, also known as C...

February 25, 2021
Industry
Christopher Ko shares visions as Bio association representative

South Korean biosimilar maker Samsung Bioepis’ CEO Christopher Ko on Wednesday carried out his first public event as the new chairperson of the Korea Bio Association. Korea Bio is an association rep...

February 24, 2021
Industry
Elekta’s next-gen MRI device offers new hope for cancer patients

Swedish medical device company Elekta wants to give renewed hopes to cancer patients through its next-generation radiotherapy device Unity. Elekta on Wednesday launched Unity in Korea, making it the...

February 24, 2021
Industry
Korean experts advise Pfizer vaccine for 16 and older

The first of the three-part evaluation of Pfizer’s COVID-19 vaccine here has shown the vaccine to be 95 percent effective and eligible for use on those aged 16 and older, South Korea’s Drug Ministry ...

February 23, 2021
Industry
[Herald Interview] Software dons role of therapeutics

When talking about medical devices, conventional hardware with analytical or therapeutic functions for human health usually come to mind. But computer software that seeks to cure or alleviate sympto...

February 22, 2021
Industry
Macrogen, Lifex Biolabs to research Parkinson’s treatment

Precision life science company Macrogen will collaborate with US-based Lifex Biolabs on Parkinson’s disease treatment research, Macrogen announced Monday. This is a follow-up to Macrogen’s strategic...

February 22, 2021
Industry
Samsung Display joins responsible business alliance

Samsung Display’s chief executive officer Choi Joo-sun is aiming to further embolden the company’s environmental, social and governance (ESG) involvement beginning this year. As part of this drive, ...

February 21, 2021
Industry
Celltrion to take on S. Africa variant

Only a day after Celltrion began distribution of its monoclonal antibody therapy for COVID-19 in Korea, the company announced Thursday that it is setting out to tackle the more contagious South Afric...

February 18, 2021
Industry
Celltrion begins distribution of COVID-19 therapy in Korea

Celltrion began nationwide distribution of its monoclonal antibody therapy for COVID-19 on Wednesday. Celltrion’s regdanvimab is Korea’s first emergency-approved COVID-19 treatment. All 156 state-d...

February 17, 2021
Industry
[News Focus] More homegrown COVID-19 therapies coming

Following Celltrion’s monoclonal antibody treatment for COVID-19, a slew of homegrown therapies is on the way in the first half of 2021. Chong Kun Dang Pharmaceutical is set to submit application fo...

February 16, 2021
Industry
SK Bioscience to manufacture Novavax vaccine for 20 mil population

South Korean vaccine-maker SK Bioscience will manufacture 40 million doses of US’ Novavax vaccines, enough to inoculate 20 million people. Under the agreement signed by SK Bioscience, Korea Disease ...

February 16, 2021
Industry
Celltrion’s Humira biosimilar gains European sales approval

Celltrion’s Yuflyma, an adalimumab biosimilar for autoimmune diseases, has been given the green light by the European Commission on Feb. 11, allowing for it to be sold in the European market, Celltri...

February 15, 2021
Industry

The Korea Herald by Herald Corporation

Address : Huam-ro 4-gil 10, Yongsan-gu,Seoul, Korea
Online newspaper registration No : Seoul 아03711
Date of registration : 2015.04.28
Publisher. Editor : Kwon Chung-won
Juvenile Protection Manager : Yang Sung-jin
Tel : 02.727.0114